A new study identifies recurrent somatic duplications of a NOTCH1-driven enhancer of MYC in human T cell leukemia. This enhancer is required for both normal and malignant T cell development.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Katie Vicari/Nature Publishing Group
References
Taub, R. et al. Proc. Natl. Acad. Sci. USA 79, 7837–7841 (1982).
Adams, J.M. et al. Nature 318, 533–538 (1985).
Ferrando, A.A. et al. Blood 103, 1909–1911 (2004).
Ley, T.J. et al. Nature 456, 66–72 (2008).
Herranz, D. et al. Nat. Med. 20, 1130–1137 (2014).
Weng, A.P. et al. Genes Dev. 20, 2096–2109 (2006).
Hnisz, D. et al. Cell 155, 934–947 (2013).
Chiang, M.Y. et al. J. Clin. Invest. 118, 3181–3194 (2008).
Radtke, F. et al. Immunity 10, 547–558 (1999).
Dose, M. et al. Blood 108, 2669–2677 (2006).
Huang, F.W. et al. Science 339, 957–959 (2013).
Horn, S. et al. Science 339, 959–961 (2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Pouliot, G., Gutierrez, A. Thymocyte transformation enhanced. Nat Med 20, 1096–1097 (2014). https://doi.org/10.1038/nm.3711
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.3711
